fbpx
Revolutionizing Cancer Treatment: How Immune System Harnessing and Science-Driven Drug Design are Saving Lives

Revolutionizing Cancer Treatment: How Immune System Harnessing and Science-Driven Drug Design are Saving Lives

The groundbreaking CAR T cell therapy has revolutionized cancer treatments, turning the field from chance-based to one guided by scientific drug design. This evolution is ushering in new drug developments and stirring broader interest beyond oncology. Penn Medicine has played an integral role in FDA-approved treatments, reflected by the significant reduction in cancer mortality. The approval of CAR T cell therapy, a treatment that harnesses the immune system against cancer, is a momentous milestone in oncology. Penn Medicine's research substantially contributes to our expanding understanding of cancer biology. The potential of CAR T extends beyond oncology, potentially offering new treatments for autoimmune diseases. The successful development of innovative meds such as olaparib and pafolacianine, treatments for ovarian and breast cancer, respectively, represents the progress we've made in this field. The sharp decline in U.S. cancer mortality since 1991 is further proof of these advancements' effectiveness. While the revolution in cancer treatment is just starting, every new discovery brings us a step closer to transforming cancer from a deadly disease to a manageable, sometimes curable, condition.

Full article here: https://medium.com/@lawsuithelpdesk/revolutionizing-cancer-treatment-how-immune-system-harnessing-and-science-driven-drug-design-are-07c70893eb89

YouTube
LinkedIn
LinkedIn
Share